1 / 9

Updated EULAR Recommendations for Gout Diagnosis

Explore the revised evidence-based guidelines for diagnosing gout in rheumatology and primary care settings, incorporating clinical algorithms and imaging techniques. Aimed at healthcare providers managing gout patients.

Download Presentation

Updated EULAR Recommendations for Gout Diagnosis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. 2018 Updated EULAR Evidence-based Recommendations for the Diagnosis of Gout

  2. Slide 1: Target population/question • In 2006, the EULAR produced its first evidence-based recommendations for the diagnosis of gout. Since then, a number of studies have explored the diagnostic value of clinical algorithms and of imaging modalities such as ultrasound (US) or dual-energy computed tomography (DECT). This prompted a revision of the 2006 recommendations following an updated systematic literature review (SLR) and a Delphi process to achieve consensus • Target population: Rheumatologists, GPs, and all Health care providers who manage people with Gout

  3. Slide 2: Methods/methodological approach • Methods: According to the EULAR Standardized Operating Procedures* Consensual approach Systematic literature research Consensual approach FINAL Recommendations * van der Heijde et al Ann Rheum Dis 2016,75:3-15

  4. Slides 3-4: Overarchingprinciples • Since we formulated only 8 recommendations, we did not propose overarching principles

  5. Slides 5-15: Individual Recommendations

  6. Slide 16: Summary Table Oxford Level of Evidence

  7. Slides 17-18: Summary of Recommendations in bullet point format • The task force recommends a three step approach for the diagnosis of gout • The first step relies on MSU crystal identification when SF analysis is feasible. • If not possible, the second step relies on a clinical diagnosis based on suggestive and associated clinical features of gout and presence of hyperuricemia. • When a clinical diagnosis of gout is uncertain and crystal identification is not possible, the third step recommends imaging, particularly ultrasound, to search for crystal deposits. • [Secretariat will add link of recommendation once available online on BMJ portal.]

  8. Slides 19-20: Summary of Recommendations in lay format Read the full lay summary (add hyperlink if provided) 1 star (*) means it is a weak recommendation with limited scientific evidence; 2 stars (**) means it is a weak recommendation with some scientific evidence; 3 stars (***) means it is a strong recommendation with quite a lot of scientific evidence; 4 stars (****) means it is a strong recommendation supported with a lot of scientific evidence. Recommendations with just 1 or 2 stars are based mainly on expert opinion and not backed up by appropriate clinical studies, but may be as important as those with 3 and 4 stars.

  9. Slide 21: Acknowledgements • This paper is dedicated to the memory of Dr Victoria Barskova. The task force thanks EULAR for financial and logistic support.

More Related